Literature DB >> 24144794

Bradykinin contracts rat urinary bladder largely independently of phospholipase C.

Carsten Sand1, Martin C Michel.   

Abstract

Several receptor systems in the bladder causing detrusor smooth muscle contraction stimulate phospholipase C (PLC). PLC inhibition abolishes bladder contraction via P2Y6 but not that via M3 muscarinic receptors, indicating a receptor-dependent role of PLC. Therefore, we explored the role of PLC in rat bladder contraction by bradykinin. The PLC inhibitor U 73,122 [1-(6-[([17β]-3-methoxyestra-1,3,5[10]-trien-17-yl)-amino]hexyl)-1H-pyrrole-2,5-dione] did not affect the bradykinin response to a significantly greater degree than its inactive analog U 73,343 [10 μM each; 1-(6-[-([17β]-3-methoxyestra-1,3,5[10]-trien-17-yl)-amino]hexyl)-2,5-pyrrolidinedione], whereas the phospholipase D inhibitor butan-1-ol relative to its inactive control butan-2-ol caused a weak but significant inhibition (0.3% each). The cytosolic phospholipase A2 inhibitor arachidonyltrifluoromethyl ketone (300 μM) and the cyclooxygenase inhibitor indomethacin (10 μM) caused strong inhibition of the bradykinin response. The L-type Ca(2+) channel blocker nifedipine (10-100 nM) concentration-dependently caused strong inhibition, whereas only a small but significant inhibition was seen with SK&F 96,365 [10 μM; 1-[β-[3-(4-methoxyphenyl)propoxy]-4-methoxyphenethyl]-1H-imidazole HCl], an inhibitor of receptor-operated Ca(2+) channels. Several protein kinase C inhibitors yielded an equivocal picture (inhibition by 10 μM bisindolylmaleimide I and 1 μM calphostin but not by 10 μM chelerythrine). The rho kinase inhibitor Y 27,632 [1-10 μM; trans-4-[(1R)-1-aminoethyl]-N-4-pyridinylcyclohexanecarboxamide] caused a strong and concentration-dependent inhibition of the bradykinin response. Our data support that not only M3 but also bradykinin receptors cause bladder contraction by a largely PLC-independent mechanism. Both responses strongly involve L-type Ca(2+) channels and rho kinase, whereas only the bradykinin response additionally involves the phospholipase A2/cyclooxygenase pathway.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24144794     DOI: 10.1124/jpet.113.208025

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  7 in total

1.  Preclinical research strategies for newly approved drugs as reflected in early publication patterns.

Authors:  Ursula Köster; Ingo Nolte; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-11-26       Impact factor: 3.000

2.  How significant are your data? The need for a culture shift.

Authors:  Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-30       Impact factor: 3.000

3.  Normalization of organ bath contraction data for tissue specimen size: does one approach fit all?

Authors:  Betul R Erdogan; Irem Karaomerlioglu; Zeynep E Yesilyurt; Nihal Ozturk; A Elif Muderrisoglu; Martin C Michel; Ebru Arioglu-Inan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-09-11       Impact factor: 3.000

Review 4.  Central role of the BK channel in urinary bladder smooth muscle physiology and pathophysiology.

Authors:  Georgi V Petkov
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

5.  The Inhibitory Mechanism on Acetylcholine-Induced Contraction of Bladder Smooth Muscle in the Streptozotocin-Induced Diabetic Rat.

Authors:  Jong Soo Han; Su Jin Kim; Yoonjin Nam; Hak Yeong Lee; Geon Min Kim; Dong Min Kim; Uy Dong Sohn
Journal:  Biomol Ther (Seoul)       Date:  2019-01-01       Impact factor: 4.634

6.  β3-Adrenoceptor-mediated relaxation of rat and human urinary bladder: roles of BKCa channels and Rho kinase.

Authors:  Hana Cernecka; Kim Kersten; Harm Maarsingh; Carolina R Elzinga; Igle Jan de Jong; Cees Korstanje; Martin C Michel; Martina Schmidt
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2015-05-09       Impact factor: 3.000

7.  The change of signaling pathway on the electrical stimulated contraction in streptozotocin-induced bladder dysfunction of rats.

Authors:  Jong Soo Han; Young Sil Min; Gil Hyung Kim; Sang-Hyun Chae; Yoonjin Nam; Jaehwi Lee; Seok-Yong Lee; Uy Dong Sohn
Journal:  Korean J Physiol Pharmacol       Date:  2018-08-27       Impact factor: 2.016

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.